Dr. Sean Michael Wrenn, MD

Dr. Wrenn practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Wrenn's NPI, 1831431261, was assigned on March 24, 2013. Dr. Wrenn graduated from Rush Medical College in 2013. Dr. Wrenn holds Illinois license 036-153599.

Dr. Wrenn's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Wrenn's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Wrenn is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Wrenn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wrenn practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Wrenn's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Wrenn is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Wrenn's licenses on file in 4 states: Illinois, Massachusetts, Maine and Vermont.

Dmand AI lists thyroid surgery among the conditions Dr. Wrenn treats.

CMS data shows 398 Medicare services from Dr. Wrenn across 12 procedure codes in 2024, for 178 Medicare patients. Medicare paid $55,083 for them.

CMS counts 178 Medicare patients who saw Dr. Wrenn in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wrenn's median patient age at 67, with 79% women.

In 2024, Dr. Wrenn wrote 115 Medicare Part D claims for 50 patients. 86% of them were for generic drugs. CMS names the drug for 70 of them, across 2 drugs with 11 or more claims each, at $623 in total drug cost. In 2023, CMS named 49 claims across 1 drug.

Dr. Wrenn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wrenn as offering telehealth.

Dmand AI links 29 papers to Dr. Wrenn, published from 2012 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Thyroid Neoplasms, Adrenal Cortex Neoplasms and Adrenocortical Carcinoma. Dr. Wrenn has published most often in JAMA Otolaryngol Head Neck Surg. Dr. Wrenn's most frequent co-authors are Trishul Kapoor, MD, Antoine Eskander, MD and Rajshri Mainthia Gartland, MD.

CMS Open Payments shows 2 general payments to Dr. Wrenn from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Exelixis Inc. paid the most, $87.

Dmand AI lists 5 awards for Dr. Wrenn, most recently 2nd Place, Podium Presentation in 2017.

Dr. Wrenn graduated from Rush Medical College in 2013. Dr. Wrenn is a member of ACS, ATS, ASTS and SAGES.

Dr. Wrenn is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.